1. 5001PCSK9-Inhibitor treatment of cardiovascular high risk patients in a real-world setting. (28th August 2018) Authors: Kassner, U; Hollstein, T; Grenkowitz, T; Scharnagl, H; Maerz, W; Steinhagen-Thiessen, E Journal: European heart journal Issue: Volume 39(2018)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. High individual variability in LDL-reductions after inclisiran administration in a "real-world setting". (3rd October 2022) Authors: Makhmudova, U; Schatz, U; Kassner, U; Axthelm, C; Rohn, B; Westhoff, T; Vogt, A; Scholl, M; Stach, K; Sinnig, D L; Stuerzebecher, P; Schulze, P C; Landmesser, U; Laufs, U; Weingaertner, O Journal: European heart journal Issue: Volume 43(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗